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The ﬁrst edition of Biopsy Pathology of the Breast appeared in
1985. Between then and 2000, which is when John Sloane
completed his edition before his untimely death, things have
changed considerably in the ﬁeld of breast pathology. Mammo-
graphic screening is now used extensively with national
programmes, which has brought about changes in practice and
in the nature of the lesions identiﬁed. Pathologists play important
roles in the decision making processes of the multidisciplinary
team meetings.
The second edition of Biopsy Pathology certainly reﬂects these
developments. The number of chapters has expanded, and are
now quite diverse. Pathological examination includes a clear
description of dealing with mammographically detected and loca-
lised lesions. Minimum data sets and quality assurance are
considered under the section on reporting. The chapter on histo-
chemical methods has been extended to include
immunohistochemistry and molecule technique. This is a mixture
of markers of value in diagnosis, e.g. basement membrane, recep-
tors, and research orientated markers. Non-operative diagnosis
includes a section on core biopsy, with criteria used in screening.
The section on non-neoplastic epithelial changes now includes
detailed descriptions of radial scar/complex sclerosing lesions with
useful comments.
A problem area that gets most people consulting the books (and
checking deﬁnitions) is that of atypical hyperpasia. There is a
detailed description of the problems in diagnosing this lesion,
and the molecular changes, but more illustrations would have been
of value. The chapter on ductal carcinoma in situ has a detailed
review of the various classiﬁcation systems, and covers rarer types,
pathological features relating to recurrence and molecular altera-
tions. The chapter on lobular in situ neoplasia presents current
thinking. Premalignancy in the breast has similarly been up dated
to include molecular studies.
All of the common and rarer types of invasive carcinomas are
described with comments about the important pathological and
behavioural features, including recent data such as cancers occur-
ring in patients with inherited syndromes. Morphological and
molecular features of prognostic signiﬁcance are covered separately.
The chapter on ﬁbroadenoma/phyllodes tumours has been
expanded and updated. The rest of the book deals with miscella-
neous lesions.
The illustrations are a mixture of black and white and colour.
The latter are generally of a better standard. In places more
ﬁgures would be of beneﬁt for the pathologist trying to sort
out a problem or ensure that he/she is following the guidelines.
In this sense it is not really a ‘biopsy’ pathology book since it
is a book to read to ﬁnd out about recent advances and thinking
rather than as a bench book to sort out problems. It could there-
fore be of value to a wide range of people – those in training,
researchers wanting a breadth of information, pathologists –
but not necessarily those wanting to solve that diagnostic
problem. Hopefully it will be kept updated by those who have
undertaken the editing of this book which contains so much of
the experience and views of the late John Sloane.
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